Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is 1 of the best small-cap biotech stocks to bargain according to analysts.
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results connected November 6, 2025. The 4th marked continued advancement of its muscular dystrophy and cardiac programs. Meanwhile, its captious GRAND CANYON cohort for sevasemten successful Becker muscular dystrophy remains well-positioned for readout successful Q4 2026. At the aforesaid time, the MESA open-label hold proceedings noted continued enrollment of astir each eligible participants. The 4th besides saw the Phase 2 CIRRUS-HCM proceedings of EDG-7500 successful hypertrophic cardiomyopathy progressing well, with a programme update expected successful Q4 2025. Phase 1 dosing of EDG-15400 for bosom nonaccomplishment besides kicked off.
Due to the objective enactment successful EDC-15400, EDC-7500, and the sevasemten program, R&D expenses surged by $3.9 cardinal to $37.5 million, compared to the aforesaid 4th a twelvemonth earlier. With G&A expenses up $0.3 cardinal sequentially, Edgewise Therapeutics, Inc. (NASDAQ:EWTX) recorded a nett nonaccomplishment of $40.7 million, oregon $0.39 per share.
Yet Edgewise Therapeutics, Inc. (NASDAQ:EWTX) closed the 4th with $563.3 cardinal successful currency balances, capable to supply a runway to enactment ongoing objective improvement and imaginable aboriginal commercialized launches.
Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a biopharmaceutical company, develops caller therapies for muscular dystrophies and superior cardiac conditions.
While we admit the imaginable of EWTX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 7 Best Oil and Gas Penny Stocks to Buy According to Analysts and Billionaire Jacob Rothschild’s RIT Capital Partners: 9 Stocks with Huge Upside Potential.
Disclosure: None.

2 weeks ago
7



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·